Kevin Laliberte
2018
In 2018, Kevin Laliberte earned a total compensation of $1.4M as Senior Vice President, Product Development at Dova Pharmaceuticals.
Compensation breakdown
| Option Awards | $1,081,442 |
|---|---|
| Salary | $337,500 |
| Other | $9,285 |
| Total | $1,428,227 |
Laliberte received $1.1M in option awards, accounting for 76% of the total pay in 2018.
Laliberte also received $337.5K in salary and $9.3K in other compensation.
Rankings
In 2018, Kevin Laliberte's compensation ranked 7,397th out of 14,244 executives tracked by ExecPay. In other words, Laliberte earned more than 48.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,397 out of 14,244 | 48th |
Division Manufacturing | 2,872 out of 5,765 | 50th |
Major group Chemicals And Allied Products | 1,080 out of 2,128 | 49th |
Industry group Drugs | 913 out of 1,817 | 50th |
Industry Pharmaceutical Preparations | 716 out of 1,391 | 49th |
Source: SEC filing on March 15, 2019.
Laliberte's colleagues
We found three more compensation records of executives who worked with Kevin Laliberte at Dova Pharmaceuticals in 2018.